Azure Functions shipped a serverless agents runtime in public preview at Build 2026. Agents are defined in .agent.md markdown ...

AI research from Microsoft shows that large‑scale LLMs use far less energy and water per query, improving efficiency and ...

Your weekly cybersecurity recap: a GitHub supply chain worm, an exploited Android flaw, Instagram account takeovers, and a ...

Private factory PMI beat forecasts but slowed from April. Export orders and manufacturing employment weakened in May. Official data pointed to softer industrial growth across China. In this article ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

Referring to it as a “paradigm shift” for the central Louisiana economy, state and local officials on Tuesday announced a $3.6 billion data center in Rapides Parish that is expected to create 200 jobs ...

Josh and Spencer Marentette, who also have an action feature set up at Amazon, penned the screenplay. By Ryan Gajewski Senior Entertainment Reporter Plot details for Run the Football are being kept ...

A threat actor targeting Microsoft 365 and Azure production environments is stealing data in attacks that abuse legitimate applications and administration features. Microsoft tracks the actor as Storm ...

Microsoft today confirmed that customers will be able to run cloud workloads from its Saudi Arabia East datacenter region from Q4 2026, marking a major milestone in the company’s long-term investment ...

The data centres powering the AI boom already use more electricity than some small countries, and the International Energy Agency projects that their demand could reach 945 terawatt-hours a year – ...

Microsoft’s Azure cloud business accelerated in the March quarter, growing 40% and topping the company’s own forecast, giving the tech giant a new answer to questions about its ability to translate ...

An analyst named the death of a patient as a potential explanation for the stock drop. (Lynn Fenn/iStock/Getty Images Plus) Erasca has backed up bullish claims about its pan-RAS drug having a ...